Powder: -20°C for 3 years | In solvent: -80°C for 1 year
VEGFR-2-IN-23 (compound 11b) is a highly potent and selective inhibitor of VEGFR-2, with an impressive IC 50 value of 0.34 nM. This compound exhibits notable antitumor activity, capable of inducing apoptosis and cell cycle arrest specifically at the G1 phase [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | VEGFR-2-IN-23 (compound 11b) is a highly potent and selective inhibitor of VEGFR-2, with an impressive IC 50 value of 0.34 nM. This compound exhibits notable antitumor activity, capable of inducing apoptosis and cell cycle arrest specifically at the G1 phase [1]. |
In vitro | VEGFR-2-IN-23 (compound 11b) demonstrates antitumor efficacy by presenting IC50 values of 23, 0.8, 1.3, and 46 nM against PC3, DU145, MCF-7, and MDA-MB435 cancer cell lines, respectively [1]. |
In vivo | VEGFR-2-IN-23, administered intraperitoneally at doses of 5 and 10 mg/kg, effectively suppresses tumor growth in MCF-7 xenograft models [1]. |
Molecular Weight | 381.39 |
Formula | C22H15N5O2 |
CAS No. | 2411174-53-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
VEGFR-2-IN-23 2411174-53-1 inhibitor inhibit